GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **2376 - 2400** of **4050** in total

« First

‹ Prev

…

92

93

94

95

96

97

98

99

100

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▼
IgM	Patient 4	12	mild	G19868AX	147
IgM	Patient 2	15	mild	G17266GE	146
IgM	Patient 2	15	mild	G19868AX	146
IgM	Patient 2	24	mild	G48898TH	146
IgM	Patient 2	24	mild	G73271MD	146
IgM	Patient 3	-180	mild	G36191CD	146
IgG	Patient 3	4	mild	G82096UQ	146
IgG	Patient 4	12	mild	G58969RU	146
IgM	Patient 2	15	mild	G73271MD	145
IgM	Patient 2	3	mild	G62826CL	145
IgM	Patient 3	11	mild	G58547FH	145
IgM	Patient 4	12	mild	G02557XE	145
IgM	Patient 2	24	mild	G08340FW	144
IgM	Patient 2	24	mild	G17390SF	144
IgG	Patient 3	11	mild	G82096UQ	144
IgM	Patient 3	4	mild	G25473LQ	144
IgM	Patient 1	22	moderate	G24617OK	143
IgM	Patient 1	6	moderate	G60761LT	143
IgG	Patient 2	3	mild	G00057MO	143
IgM	Patient 2	24	mild	G82348BZ	143
IgM	Patient 2	3	mild	G65889KE	143
IgM	Patient 3	4	mild	G92823JK	143
IgG	Patient 4	12	mild	G90562PB	143
IgM	Patient 1	22	moderate	G32473MI	142
IgM	Patient 1	22	moderate	G57449OF	142